microRNA profiling in duodenal ulcer disease caused by Helicobacter pylori infection in a Western population

S Lario1, M J Ramírez-Lázaro, A M Aransay

  • 1Departament de Medicina, Digestive Diseases Service, Hospital de Sabadell, Institut Universitari Parc Taulí, Universitat Autònoma de Barcelona, Sabadell, Barcelona, Spain.

Insights

MicroRNA (miRNA) expression changes in Helicobacter pylori infection were analyzed. Specific miRNAs were linked to chronic-active gastritis, but not duodenal ulcers, in H. pylori patients.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Infectious Diseases

Background:

  • MicroRNAs (miRNAs) are increasingly linked to various diseases.
  • Their role in chronic infections like Helicobacter pylori remains underexplored.
  • Helicobacter pylori infection is a common cause of gastritis and duodenal ulcers.

Purpose of the Study:

  • To compare miRNA expression profiles in patients with H. pylori-induced duodenal ulcers (DU), H. pylori-infected patients without DU, and uninfected individuals.
  • To identify specific miRNAs associated with H. pylori infection and gastritis.
  • To investigate the correlation between miRNA expression and host inflammatory response molecules.

Main Methods:

  • Microarray analysis of miRNA expression in antral mucosal samples from dyspeptic patients (n=46).
  • Validation of significant miRNA findings in an independent patient cohort (n=42) using PCR.
  • Analysis of mRNA transcripts for cytokines (IL8, IL12p40, IL12p35, IL23p19), signaling molecules (MYD88, GATA6, SOCS2, STAT6), and H. pylori virulence factors (cagA, VacA).

Main Results:

  • Seventeen miRNAs were deregulated in H. pylori-infected patients; no significant differences were found between normal and DU patients.
  • Up-regulation of miR-9, miR-146a, miR-155, and miR-650, and down-regulation of miR-96 and miR-204 were confirmed.
  • miR-9, miR-96, miR-146a, and miR-650 expression was specific to chronic-active gastritis.
  • H. pylori-infected patients showed altered mRNA levels of IL8, IL12p40, GATA6, and SOCS2.
  • Down-regulation of GATA6, MYD88, SOCS2, and STAT6 was observed in gastritis, but not correlated with validated miRNA changes.

Conclusions:

  • Specific miRNA expression profiles are associated with H. pylori infection and chronic-active gastritis.
  • The observed miRNA changes are not directly linked to duodenal ulcer development in H. pylori patients.
  • Further research is needed to elucidate the precise functional role of these altered miRNA expressions in the context of H. pylori infection.

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...